International Clinical Trial: The Role of Interferon-Induced Protein 44-Like (IFI44L) Promoter Methylation in the Early Diagnosis and Disease Activity Assessment of Takayasu Arteritis

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115680) titled 'The Role of Interferon-Induced Protein 44-Like (IFI44L) Promoter Methylation in the Early Diagnosis and Disease Activity Assessment of Takayasu Arteritis' on Dec. 30, 2025.

Study Type: Observational study

Study Design: Factorial

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

Condition: Patients with Takayasu Arteritis

Intervention: Takayasu Arteritis Group:None Atherosclerosis Group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Takayasu Arteritis Group:80;Atherosclerosis Group:50;Healthy contral:30;

Countries of Re...